April 25, 2024
Loading...
You are here:  Home  >  Top Stories  -  Page 5
Latest

Geri LaChance, SESLOC CEO, retiring in June

By   /  Wednesday, January 10th, 2024  /  Banking & Finance, Banking Industry, left, Nonprofits, Regions, San Luis Obispo County, Top Stories, Top Story  /  Comments Off on Geri LaChance, SESLOC CEO, retiring in June

Geri LaChance, president and CEO of the SESLOC Federal Credit Union for 12 years, is retiring effective June 2024, the San Luis Obispo-based nonprofit announced Jan. 10. She will be succeeded by Mike Quamma, the organization’s executive vice president and CFO. SESLOC Board Chair Tom Lebens praised LaChance’s tenure. “It’s hard to aptly summarize the Read More →

Latest

Optimism is high for tri-county travel sector in ‘24

By   /  Monday, January 8th, 2024  /  Central Coast, Economy, Latest news, Subscriber content, Top Stories, Top Story, Tourism, Tri-County Economy  /  Comments Off on Optimism is high for tri-county travel sector in ‘24

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Generative AI will take off in 2024, area experts say

By   /  Thursday, January 4th, 2024  /  Latest news, Technology, Top Stories, Top Story, Tri-County Economy  /  Comments Off on Generative AI will take off in 2024, area experts say

2024 will be the year of the new wave of artificial intelligence — generative AI — Tri-County experts in the field say. Most, if not all, AI companies and other businesses that use AI will be dialing into the cutting-edge technology more and more, the specialists say. They include those in the Central Coast region Read More →

Latest

MannKind inks royalty purchase agreement for up to $200M

By   /  Tuesday, January 2nd, 2024  /  Central Coast, Health Care & Life Science, Latest news, Top Stories, Top Story  /  Comments Off on MannKind inks royalty purchase agreement for up to $200M

Westlake Village-based MannKind Corporation saw shares climb 8% on Jan. 2 after the company announced entering into a royalty purchase agreement of up to $200 million. MannKind, a biotechnology company that develops treatments for diabetes and pulmonary arterial hypertension, sold a 1% royalty in net sales of Tyvaso DPI to Sagard Healthcare on Dec. 27. Read More →

Latest

Limoneira pleased by FY2023 despite revenue dip

By   /  Thursday, December 28th, 2023  /  Agribusiness, Earnings, Regions, Subscriber content, Top Stories, Top Story, Tri-County Public Companies, Ventura County  /  Comments Off on Limoneira pleased by FY2023 despite revenue dip

Despite a 2.5% dip in fiscal year 2023 revenues compared to fiscal year 2022, the CEO of Santa Paula-based Limoneira says he’s pleased with the agribusiness’s year-over-year performance. “We achieved our full-year avocado and revised lemon volume guidance despite harsh weather conditions and softer lemon pricing throughout most of the year,” Harold Edwards said during Read More →

Latest

Central Coast developer hit with new federal charges

By   /  Tuesday, December 26th, 2023  /  Latest news, Law & Goverment, Top Stories, Top Story  /  Comments Off on Central Coast developer hit with new federal charges

A Central Coast developer already charged with bribing a Santa Barbara County supervisor has been hit with new charges alleging that he participated in a scheme to defraud investors in a Texas real estate project. A federal grand jury returned the latest indictment against Ryan Wright, 37, also known as “Ryan Petetit,” of Grover Beach, Read More →

Latest

Arcutis’ treatment gets additional FDA approval

By   /  Friday, December 22nd, 2023  /  Health Care & Life Science, Latest news, Subscriber content, Top Stories, Top Story, Tri-County Economy  /  Comments Off on Arcutis’ treatment gets additional FDA approval

Westlake Village-based Arcutis Biotherapeutics announced that its main treatment option, Zoryve, received approval from the U.S. Drug and Food Administration for treating a skin condition called seborrheic dermatitis, the company announced on Dec. 15 It is the second FDA approval received by Arcutis’ Zoryve, being approved to be used in individuals nine years of age Read More →